Clinical & translational oncology

• 

  Año 2015, Vol. 17, Número 11

  • Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers

    Z. Wei, W. Gao, B. Ni, Y. Tian

    • Resumen

    págs. 841-846

    

  • Salivary gland myoepithelial carcinoma

    S. Vilar-González, K. Bradley, J. Rico Pérez, P. Vogiatzis, D. Golka, A. Nigam, M. Sivaramalingam, S. Kazmi

    • Resumen

    págs. 847-855

    

  • Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

    Nieves Martínez Lago, M. Vieito Villar, Allan Luke, María Elena Padin Iruegas, Francisca Vázquez Rivera, Sonia Candamio Folgar, A. Atarés del Campo

    • Resumen

    págs. 856-861

    

  • Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

    Silvia Antolín Novoa, Esperanza Blanco Campanario, A. Antón Torres, M.I. Gallegos Sancho, R. Pérez Carrión, Ignacio Peláez Fernández, Antonio Galán, Luis de la Cruz-Merino, Adolfo Murias Rosales

    • Resumen

    págs. 862-869

    

  • Hepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases

    W.-G Qiang, L, R. Shi, Q Q Wu, J. M. Zhao, L. J. Chen, Y. Yang

    • Resumen

    págs. 870-875

    

  • MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer

    Z Sun, N. Zhou, Q. Han, L. Zhao, C. Bai, Y. Chen

    • Resumen

    págs. 876-883

    

  • Autologous tumor lysate/Bacillus Calmette�Guérin immunotherapy as an adjuvant to conventional breast cancer therapy

    Jacinto Convit, H Montesinos, H. Oviedo, Gabriel Romero, B. Maccarone, E. Essenfeld, A. Convit, L. E Palacios

    • Resumen

    págs. 884-887

    

  • Systemic chemotherapy as a main strategy for liver metastases from gastric cancer

    W. Zhang, Y. Yuan, Y. Fang, Y. Cui, K Shen, T. Liu

    • Resumen

    págs. 888-894

    

  • The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival

    Basak Oven Ustaalioglu, Mónica Szurmuk, Ahmet Bilici, Mehmet Aliustaoglu, Fugen Aker Vardar, Burcak Erkol Yilmaz

    • Resumen

    págs. 895-902

    

  • miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12

    Y. Lv, Y Lei, W Ding, C. Zhang, C Fang

    • Resumen

    págs. 903-909

    

  • Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies

    C V. Sole, Felipe A. Calvo Manuel, S. Lizarraga, Luis González Bayón, José Luis García Sabrido

    • Resumen

    págs. 910-916

    

  • Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis

    F. Kong, Y. Qi, H. Liu, F. Gao, P. Yang, Y Li

    • Resumen

    págs. 917-924

    

  • Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma

    F. Puebla, María Camino Urdiales, Raul Matute, I. Marrone, C. Iglesias Miguez, D. Sevillano, A. Sánchez Reyes, Eleonor Rivín del Campo

    • Resumen

    págs. 925-931

    

  • GRP78 and a2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment

    P. J. Vlachostergios, R. Daya, R. L Balmiki

    págs. 932-934

    

  • Retraction Note to: Profiling of differentially expressed microRNAs (miRNAs) during differentiation of rat hepatic oval cells (HOCs) into hepatocellular carcinoma (HCC) cells

    R. H. Xu, L. Y. Zheng, D. L. He, J. Meng, Warren Moran, X. B. Hao, zz Zhan

    págs. 935-936